Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-005461
Filing Date
2019-03-01
Accepted
2019-03-01 16:36:52
Documents
1
Period of Report
2019-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3968
  Complete submission text file 0000899243-19-005461.txt   5347
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

EIN.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1188 BROADWAY, SUITE 306 SOMERVILLE MA 02144
Business Address
BORMANN-KENNEDY BARBARA-JEAN ANNE (Reporting) CIK: 0001635065 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 19649995